Literature DB >> 25331624

Large fundal varices: to glue or not to glue?

Syed Adnan Mohiuddin1, Manik Sharma1, Ragesh Babu Thandassery1, Muneera Al Mohannadi1, Rafie Yakoob1, Ahmed Muzrakchi2, Saad Rashid Al Kaabi1.   

Abstract

Entities:  

Year:  2014        PMID: 25331624      PMCID: PMC4188957     

Source DB:  PubMed          Journal:  Ann Gastroenterol        ISSN: 1108-7471


× No keyword cloud information.
A 45-year-old man was admitted with a one-day history of hematemesis and melena. He was had been followed up for chronic hepatitis C-related cirrhosis and had been admitted previously for management of spontaneous bacterial peritonitis. He was hemodynamically stable and general physical examination was noncontributory except for mild icterus. Investigations revealed hemoglobin 9.6 g/L, platelet count 66,000/mm3, INR 1.6, serum albumin 26 g/L, alanine transmainase 132 IU/mL, aspartate transaminase 141 IU/mL and serum bilirubin 53 mmol/L (normal <24). Abdominal ultrasound and doppler scan revealed cirrhotic liver, splenomegaly and patent hepatic and portal veins. Urgent gastroscopy revealed a large fundal varix (IGV1) with stigmata of recent bleed. He was planned for glue injection. As we injected 1 mL of glue (0.5 mL n-butyl cyanoacylate mixed with 0.5 mL lipiodol) into the fundal varix, there was active spurting (Fig. 1). The patient developed significant bleeding and became hypotensive. He was stabilized with intravenous fluids, blood transfusion and terlipressin. An attempt was made to radiologically embolize the gastrorenal shunt by Balloon Retrograde Transvenous Obliteration (BRTO). A large gastrorenal shunt was identified and embolization with absolute alcohol was attempted after balloon occlusion of the gastrorenal shunt (Fig. 2B). Four hours later a repeat venography revealed rupture of the balloon with minimal obliteration of collaterals. As the patient was a poor risk candidate for surgical devascularization, a second attempt was made endoscopically and 3 mL of glue (1.5 mL n-butyl cyanoacylate mixed with 1.5 mL lipiodol) was injected. We confirmed hardening of varix with catheter probe and the procedure was uneventful (Fig. 2B). Post procedure, the patient remained stable and was discharged a week later. He is asymptomatic on follow up after 3 months.
Figure 1

(A) Fundal varix with stigmata of recent bleeding (B) Active bleeding after glue injection

Figure 2

Venogram (A) showing large gastrorenal shunt (arrow) and (B) endoscopic appearance of varix after successful glue injection

(A) Fundal varix with stigmata of recent bleeding (B) Active bleeding after glue injection Venogram (A) showing large gastrorenal shunt (arrow) and (B) endoscopic appearance of varix after successful glue injection Gastric varices account for about one-fifth of cases of variceal bleed and can result in severe bleeding with high mortality [1]. Treatment options for fundal variceal bleeding include endoscopic injection therapy with n-butyl cyanoacrylate, radiological measures (BRTO and transjugular intrahepatic portosystemic shunt) and surgical devascularization [1,2]. Recently, use of endoscopic ultrasound-guided therapy with coils has also been advocated [3]. Various studies have recommended different volumes of glue, varying from 0.5-4 mL of glue per session with each injection consisting of not more than one mL (glue and lipiodol combined) [1-4]. In the index case, during the first session of glue injection, immediately after injection, the patient developed significant bleeding. Unfortunately, BRTO also failed in the index case. In a recent series of 41 patients who underwent BRTO, rupture of the balloon leading to technical failure of the procedure has been described in about 14% of patient [5]. As a salvage measure we injected a relatively large volume of glue (three times the usual dose per injection) to control the bleeding and this was successful. We wish to emphasize that, even in cases where initial endoscopic and radiological measures had failed, a repeat endoscopic glue injection can be attempted, especially in a large fundal varix, which can be lifesaving. Larger volumes per injection (up to 1.5 mL of glue) can result in complete obliteration of fundal varices without any significant risk of embolization.
  5 in total

1.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2010-06-27       Impact factor: 25.083

2.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Arun J Sanyal; Norman D Grace; William Carey
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

3.  Balloon-occlusion catheter rupture during balloon-occluded retrograde transvenous obliteration of gastric varices utilizing sodium tetradecyl sulfate: incidence and consequences.

Authors:  Wael E A Saad; David Nicholson; Allison Lippert; Cynthia Cindy Wagner; Cenk U Turba; Saher S Sabri; Mark G Davies; Alan H Matsumoto; John Fritz Angle
Journal:  Vasc Endovascular Surg       Date:  2012-10-12       Impact factor: 1.089

4.  A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos).

Authors:  Stefan Seewald; Tiing Leong Ang; Hiroo Imazu; Mazen Naga; Salem Omar; Stefan Groth; Uwe Seitz; Yan Zhong; Frank Thonke; Nib Soehendra
Journal:  Gastrointest Endosc       Date:  2008-09       Impact factor: 9.427

5.  EUS-guided coil versus cyanoacrylate therapy for the treatment of gastric varices: a multicenter study (with videos).

Authors:  Rafael Romero-Castro; Mark Ellrichmann; Carlos Ortiz-Moyano; Jose Carlos Subtil-Inigo; Felix Junquera-Florez; Joan B Gornals; Alejandro Repiso-Ortega; Juan Vila-Costas; Francisco Marcos-Sanchez; Miguel Muñoz-Navas; Manuel Romero-Gomez; Enric Brullet-Benedi; Javier Romero-Vazquez; Angel Caunedo-Alvarez; Francisco Pellicer-Bautista; Juan M Herrerias-Gutierrez; Annette Fritscher-Ravens
Journal:  Gastrointest Endosc       Date:  2013-07-25       Impact factor: 9.427

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.